Purdue Institute for Drug Discovery

177Lu-FAP-DOTA (LT21)

Overview: 

Fibroblast activation protein alpha (FAP)-targeted radiotherapy for the treatment of solid tumors.

Status: 

Purdue Faculty: 

Dr. Madduri Srinivasarao

Dr. Philip Low

Development Partner: 

Low Institute for Therapeutics